The Access Group
The Access Group creates and executes strategies to support the world’s leading biopharmaceutical corporations with maximizing their products’ access to managed markets and patients. Water Street acquired the company in 2016 and intends to bolster its suite of services into a broader commercialization services offering. Founded in 1998, The Access Group has grown to serve more than 90 of the world’s leading pharmaceutical companies, including most of the top ten, on products spanning 75 therapeutic areas from early-stage development through patent expiration. It offers specialized expertise and capabilities that define and communicate drug therapies’ value proposition to payers, educate the medical community on drugs and brand new medicines.